Please login to the form below

Not currently logged in
Email:
Password:

Relvar

This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

Elan buys into GSK-partnered Theravance programmes for $1bn

Elan buys into GSK-partnered Theravance programmes for $1bn

Aside from Breo ( known as Relvar outside the US), Elan will get royalties on sales of COPD combination therapy Anoro ( umeclidinium bromide and vilanterol), vilanterol as a monotherapy and GSK961081, a

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a unique medical communications consultancy providing outstandingdirector-only service tailored to individual client needs. The company philosophy is...

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....